Molecular Mechanisms of Fibroblast Growth Factor-1 Traffick, Signaling and Release

• References

• 1 Fdkman J. Angiogenesis and breast cancer. J din Oncol 1994; 12: 441-443
• 2 Schott RJ, Morrow LA. Growth factors and angiogenesis. Cardiovasc Res 1993; 27: 1155-1161
• 3 Weinstatsaslow D, Steeg PS. Angiogenesis and colonization in the tumor metastatic process -Basic and applied advances. FASEB J 1994; 8: 401-407
• 4 Freitas I, Baronzio F. Neglected factors in cancer treatment - Cellular interactions and dynamic microenvironment in solid tumors. Anticancer Res 1994; 14: 1097-1101
• 5 Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors - Regulation of angiogenesis. J Leukocyte Biol 1994; 56: 423-435
• 6 Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188
• 7 Pepper MS, Vassalli JD, Wilks JW, Schweigerer L, Orci L, Montesano R. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 1994; 55: 419-134
• 8 Burrows FJ, Thorpe PE. Vascular targeting - A new approach to the therapy of solid tumors. Pharmacol Ther 1994; 64: 155-174
• 9 Diazflores L, Gutierrez R, Varela H. Angiogenesis - An update. Histol & Histopathol 1994; 9: 807-843
• 10 Damato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-4085
• 11 O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao YH, Sage EH, Folkman J. Angiostatin-A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328
• 12 Hu DE, Hori Y, Presta M, Gresham GA, Fan TP. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 1994; 18: 45-58
• 13 Norioka K, Mi taka T, Mochizuki Y, Hara M, Kawagoe M, Nakamura H. Interaction of interleukin-1 and interferon-gamma on fibroblast growth factor-induced angiogenesis. Japanese J Cancer Res 1994; 85: 522-529
• 14 Fantl WJ, Johnson DE, Williams LT. Signaling by receptor tyrosine kinases. Annu Rev Biochem 1993; 62: 453-482
• 15 Burgess WH, and Winkles JA. The fibroblast growth factor family: Multifunctional regulators of cell proliferation. Oxford:Oxford University Press; 1994: 155-218
• 16 Pantoliano MW, Horlick RA, Springer BA, Vandyk DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994; 33: 10229-10248
• 17 Stachowiak MK, Moffett J, Joy A, Puchacz E, Florkiewicz R, Stachowiak EK. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J Cell Biol 1994; 127: 203-223
• 18 Jans DA. Nuclear signaling pathways for polypeptide ligands and their membrane receptors. FASEB J 1994; 8: 841-847
• 19 Yeoman LC. An autocrine model for cell-associated and matrix-associated fibroblast growth factor. Oncology Res 1993; 5: 489-499
• 20 Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 4: 207-218
• 21 Senger DR, Vandewater L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. . Cancer Metastasis Rev 1993; 12: 303-324
• 22 Moroianu J, Riordan JF. Nuclear translocation of angiogenic proteins in endothelial cells: An essential step in angiogenesis. Biochemistry 1994; 33: 12535-12539
• 23 Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575-606
• 24 Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J. 1995 (In Press)
• 25 Miyamoto M, Naruo K- I, Seko C, Matsumoto S, Kondo T, Kurokawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 1993; 13: 4251-4259
• 26 Mason U. The ins and outs of fibroblast growth factors. Cell 1994; 78: 547-552
• 27 Quarto N, Talarico D, Florkiewicz R, Rifkin DB. Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul 1991; 2: 699-708
• 28 Zhan X, Hu XG, Friedman S, Maciag T. Analysis of Endogenous and Exogenous Nuclear Translocation of Fibroblast Growth Factor-1 in NIH 3T3 Cells. Biochem Biophys Res Commun 1992; 188: 982-991
• 29 Zhan X, Hu X, Friesel R, Maciag T. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J Biol Chem 1993; 268: 9611-9620
• 30 Wiedlocha A, Falnes PO, Madshus IH, Sandvig K, Olsnes S. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 1994; 76: 1039-1051
• 31 Friedman S, Zhan X, Maciag T. Mutagenesis of the nuclear localization sequence in FGF-1 alters protein stability but not mitogenic activity. Biochem Biophys Res Commun 1994; 198: 1203-1208
• 32 Prudovsky I, Savion N, Zhan X, Friesel R, Xu J, Hou J, Mckeehan WL, Maciag T. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J Biol Chem 1994; 269: 31720-31724
• 33 Maciag T, Zhan X, Garfinkel S, Friedman S, Pmdovsky I, Jackson A, Wessendorf J, Hu X, Gamble S, Shi J, Brown S, Tarantini F, Zimrin A. Novel mechanisms of fibroblast growth factor-1 function. Recent Prog Hoim Res 1993; 49: 105-123
• 34 Kiefer P, Acland P, Pappin D, Peters G, Dickson C. Competition between nuclear localization and secretory signals determines the intracellular fate of a single CUG-initiated form of FGF-3. EMBO J 1994; 13: 4126-4136
• 35 Zhan X, Hu X, Hampton B, Burgess WH, Friesel R, Maciag T. Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle. . J BiolChem 1993; 268: 24427-24431
• 36 Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT. Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 1991; 11: 5113-5124
• 37 Wu H, Parsons JT. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993; 120: 1417-1426
• 38 Zhan X, Plourde C, Hu X, Friesel R, Maciag T. Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. J Biol Chem 1994; 269: 20221-20224
• 39 David-Pfeuty T, Bagrodia S, Shalloway D. Differential localization patterns of myristoylated and non-myristoylated c-Src proteins in interphase and mitotic c-Src overexpresser cells. . J Cell Sci 1993; 105: 613-628
• 40 Howell BW, Cooper JA. Csk suppression of Src involves movement of Csk to sites of Src activity. Mol Cell Biol 1994; 14: 5402-5411
• 41 Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion site kinase, ppl25fax, directs SH2-dependent binding of pp60src. Mol Cell Biol 1994; 14: 1680-1688
• 42 Mason I. Do adhesion molecules signal via FGF receptors. Curr Biol 1994; 4: 1158-1161
• 43 Burgess WH, Shaheen AM, Ravera M, Jaye M, Donohue PJ, Wipkles JA. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. . J Cell Biol 1990; 111: 2129-2138
• 44 Imamura T, Friedman SA, Gamble S, Tokita Y, Opalenik SR, Thompson JA, Maciag T. Identification of the domain within fibroblast growth factor-1 responsible for heparin-dependence. Biochim Biophys Acta. 1995 (In Press)
• 45 Kan M, Wang F, Xu J, Crabb J W, Hou J, Mckeehan WL. An Essential Heparin-Binding Domain in the Fibroblast Growth Factor Receptor Kinase. Science 1993; 259: 1918-1921
• 46 Rapraeger AC, Krafka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705-1708
• 47 Yayon A, Klagsbrun M, Esko JD, Leder P, Omitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-848
• 48 Roghani M, Mansukhani A, Dell’Era P, Bellosta P, Basilico C, Rifkin DB, Moscatelli D. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 1994; 269: 3976-3984
• 49 Talarico D, Basilico C. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway. Mol Cell Biol 1991; 11: 1138-1145
• 50 Rogelj S, Weinberg RA, Fanning P, Klagsbrun M. Basic fibroblast growth factorfused to a signal peptide transforms cells. Nature 1988; 331: 173-175
• 51 Forough R, Zhan X, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, Maciag T. Differential transforming abilities of non-secreted and secreted forms of human Fibroblast Growth Factor-1. J Biol Chem 1993; 268: 2960-2968
• 52 Robinson ML, Overbeek PA, Verran DJ, Grizzle WE, Stockard CR, Friesel R, Maciag T, Thompson JA. Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development 1995; 121: 505-514
• 53 Nabel EG, Yang Z-Y, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844-846
• 54 Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T. Heat shock induces the release of Fibroblast Growth Factor- 1 from NIH-3T3 cels. Proc Natl Acad Sci USA 1992; 89: 10691-10695
• 55 Jackson A, Tarantini F, Gamble S, Friedman S, Maciag T. Release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J Biol Chem 1995; 270: 33-36
• 56 Engleka KA, Maciag T. Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation. J Biol Chem 1992; 267: 11307-11315